Drug Shortage Report for POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE

Last updated on 2025-11-27 History
Report ID 216966
Drug Identification Number 00402206
Brand name POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE
Common or Proper name Potassium Chloride for Injection Concentrate
Company Name OMEGA LABORATORIES LIMITED
Market Status MARKETED
Active Ingredient(s) POTASSIUM CHLORIDE
Strength(s) 20mEq
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 10 x 20mL vial / fiole
ATC code B05XA
ATC description I.V. SOLUTION ADDITIVES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2025-09-30
Actual start date 2025-10-03
Estimated end date 2025-12-19
Actual end date
Shortage status Actual shortage
Updated date 2025-11-27
Company comments Product on allocation
Health Canada comments
Tier 3 Status No
Contact Address 11177 HAMON
MONTREAL, QUEBEC
CANADA H3M 3E4
Company contact information info@omegalaboratory.com - 1-800-363-0584

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v32 2025-11-27 French Compare
v31 2025-11-27 English Compare
v30 2025-10-21 French Compare
v29 2025-10-21 English Compare
v28 2025-10-16 French Compare
v27 2025-10-16 English Compare
v26 2025-10-07 French Compare
v25 2025-10-07 English Compare
v24 2025-10-07 French Compare
v23 2025-10-07 English Compare
v22 2025-10-01 French Compare
v21 2025-10-01 English Compare
v20 2025-10-01 English Compare
v19 2025-09-03 French Compare
v18 2025-09-03 English Compare
v17 2025-08-30 English Compare
v16 2025-08-26 French Compare
v15 2025-08-26 English Compare
v14 2025-08-18 French Compare
v13 2025-08-18 English Compare

Showing 1 to 20 of 32